ArticleJCO clinical cancer informatics2024

Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States.

Gurjyot K Doshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.